Squamous | 794 (68.7) |
Adenocarcinoma | 323 (27.9) |
Adenosquamous | 39 (3.4) |
Tumor measurements, mm (SD) | |
Lateral extension | 18.75 (11.7) |
Anterior-posterior extension | 14.86 (10.5) |
Depth of invasion | 9.67 (7.8) |
Uninvolved stroma | 7.65 (5.8) |
Tumor maximum diameter by pathology (%) | |
<2 cm | 656 (56.7) |
≥2 cm | 500 (43.3) |
Grade (%) | |
Well differentiated | 192 (16.6) |
Moderately differentiated | 519 (44.9) |
Poorly differentiated | 336 (29.1) |
Not reported | 109 (9.4) |
Lymphovascular space invasion (%) | |
No | 588 (50.9) |
Yes | 437 (37.8) |
Not reported | 131 (11.3) |
Depth of Invasion (%) | |
Superficial (invades <1/3 of the stroma) | 269 (23.3) |
Intermediate (invades between 1/3 and 2/3 of the stroma) | 307 (26.6) |
Deep (invades >2/3 of the stroma) | 278 (24.0) |
Not reported | 302 (26.1) |
Parametrial invasion (%) | |
No | 1090 (94.3) |
Yes | 33 (2.9) |
Not reported | 33 (2.9) |
Vaginal infiltration in the specimen (%) | |
No | 1085 (93.9) |
Yes | 30 (2.6) |
Not reported | 41 (3.5) |
Margin status (%) | |
Free margins | 1070 (92.6) |
Free but close margins (<2 mm) | 63 (5.4) |
Positive margins (invasive disease) | 16 (1.4) |
Positive margins (pre-invasive disease) | 7 (0.6) |
Number of lymph nodes (SD) | 23.51 (12.4) |
Nodal status (%) | |
Negative | 1013 (87.6) |
Positive | 143 (12.4) |
FIGO 2018 stage (%) | |
IB1 | 510 (44.1) |
IB2 | 480 (41.5) |
IIA1 | 9 (0.8) |
IIB | 14 (1.2) |
IIIC1 | 140 (12.1) |
IIIC2 | 3 (0.3) |